• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Disease and Therapy Review: Senile Dementia Product Image

Disease and Therapy Review: Senile Dementia

  • ID: 463734
  • November 2012
  • Region: Global
  • 15 Pages
  • Timely Data Resources, Inc

Disease and Therapy Reviews were developed to provide a basic understanding of the key facts about a disease and market in a quick, easy-to-read format. These reports are prepared by the senior market research team of Timely Data Resources. Each Disease and Therapy Review provides a concise analysis of the most important information about a particular disease, its treatment, and the market opportunities.

Reports begin with an overview of the condition, and also contain tables that summarize the available worldwide incidence and prevalence data for the condition, a review of current diagnosis strategies and treatment options, general information about the market size, and information about important market trends. The data contained in these reports comes from key industry secondary data sources, such as the Timely Data Resources Incidence and Prevalence Database, and Lange's Current Medical Diagnosis and Treatment. This information is supplemented by reviews of analyst reports, company reports, and medical websites. Sources and references are provided.

The Senile Dementia Disease and Therapy Review provides an overview of the condition, with incidence and prevalence numbers for major countries worldwide, information on diagnosis, and an overview of treatment. Dosing and treatment cost information is provided for various treatment types and for medication. General information on the dementia market, as well as sales of leading drugs and therapies are provided.

I. OVERVIEW
General description of the condition
Symptoms, causes and risk factors

II. INCIDENCE AND PREVALENCE
Incidence Table (Canada, Italy, UK, Worldwide)
Prevalence Table (Canada, US, Argentina, Brazil, Chile, Colombia, Mexico, Peru, Czech Republic, France, Germany, Greece, Italy, Poland, Russian Federation, Spain, Turkey, UK, Bangladesh, China, India, Indonesia, Israel, Hong Kong, Japan, Republic of Korea, Philippines, Singapore, Thailand, Vietnam, Egypt, Kenya, Morocco, South Africa, Australia, Africa, Asia, Europe, Latin America, Oceania, Worldwide)

III. DIAGNOSIS
Clinical features
Diagnostic tools and tests
Types, symptoms and characteristics table

IV. TREATMENT
Cognitive impairment
Behavioural problems

V. DOSING AND TREATMENT COSTS
Dosing for commonly prescribed drugs
Costs for commonly prescribed non-generic drugs

VI. MARKET SIZE
Market overview
Sales information for key pharmaceuticals

VII. REFERENCES/RESOURCES

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos